Cargando…

Drug-target interaction prediction via class imbalance-aware ensemble learning

BACKGROUND: Multiple computational methods for predicting drug-target interactions have been developed to facilitate the drug discovery process. These methods use available data on known drug-target interactions to train classifiers with the purpose of predicting new undiscovered interactions. Howev...

Descripción completa

Detalles Bibliográficos
Autores principales: Ezzat, Ali, Wu, Min, Li, Xiao-Li, Kwoh, Chee-Keong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5259867/
https://www.ncbi.nlm.nih.gov/pubmed/28155697
http://dx.doi.org/10.1186/s12859-016-1377-y
_version_ 1782499290676985856
author Ezzat, Ali
Wu, Min
Li, Xiao-Li
Kwoh, Chee-Keong
author_facet Ezzat, Ali
Wu, Min
Li, Xiao-Li
Kwoh, Chee-Keong
author_sort Ezzat, Ali
collection PubMed
description BACKGROUND: Multiple computational methods for predicting drug-target interactions have been developed to facilitate the drug discovery process. These methods use available data on known drug-target interactions to train classifiers with the purpose of predicting new undiscovered interactions. However, a key challenge regarding this data that has not yet been addressed by these methods, namely class imbalance, is potentially degrading the prediction performance. Class imbalance can be divided into two sub-problems. Firstly, the number of known interacting drug-target pairs is much smaller than that of non-interacting drug-target pairs. This imbalance ratio between interacting and non-interacting drug-target pairs is referred to as the between-class imbalance. Between-class imbalance degrades prediction performance due to the bias in prediction results towards the majority class (i.e. the non-interacting pairs), leading to more prediction errors in the minority class (i.e. the interacting pairs). Secondly, there are multiple types of drug-target interactions in the data with some types having relatively fewer members (or are less represented) than others. This variation in representation of the different interaction types leads to another kind of imbalance referred to as the within-class imbalance. In within-class imbalance, prediction results are biased towards the better represented interaction types, leading to more prediction errors in the less represented interaction types. RESULTS: We propose an ensemble learning method that incorporates techniques to address the issues of between-class imbalance and within-class imbalance. Experiments show that the proposed method improves results over 4 state-of-the-art methods. In addition, we simulated cases for new drugs and targets to see how our method would perform in predicting their interactions. New drugs and targets are those for which no prior interactions are known. Our method displayed satisfactory prediction performance and was able to predict many of the interactions successfully. CONCLUSIONS: Our proposed method has improved the prediction performance over the existing work, thus proving the importance of addressing problems pertaining to class imbalance in the data. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12859-016-1377-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5259867
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-52598672017-01-26 Drug-target interaction prediction via class imbalance-aware ensemble learning Ezzat, Ali Wu, Min Li, Xiao-Li Kwoh, Chee-Keong BMC Bioinformatics Research BACKGROUND: Multiple computational methods for predicting drug-target interactions have been developed to facilitate the drug discovery process. These methods use available data on known drug-target interactions to train classifiers with the purpose of predicting new undiscovered interactions. However, a key challenge regarding this data that has not yet been addressed by these methods, namely class imbalance, is potentially degrading the prediction performance. Class imbalance can be divided into two sub-problems. Firstly, the number of known interacting drug-target pairs is much smaller than that of non-interacting drug-target pairs. This imbalance ratio between interacting and non-interacting drug-target pairs is referred to as the between-class imbalance. Between-class imbalance degrades prediction performance due to the bias in prediction results towards the majority class (i.e. the non-interacting pairs), leading to more prediction errors in the minority class (i.e. the interacting pairs). Secondly, there are multiple types of drug-target interactions in the data with some types having relatively fewer members (or are less represented) than others. This variation in representation of the different interaction types leads to another kind of imbalance referred to as the within-class imbalance. In within-class imbalance, prediction results are biased towards the better represented interaction types, leading to more prediction errors in the less represented interaction types. RESULTS: We propose an ensemble learning method that incorporates techniques to address the issues of between-class imbalance and within-class imbalance. Experiments show that the proposed method improves results over 4 state-of-the-art methods. In addition, we simulated cases for new drugs and targets to see how our method would perform in predicting their interactions. New drugs and targets are those for which no prior interactions are known. Our method displayed satisfactory prediction performance and was able to predict many of the interactions successfully. CONCLUSIONS: Our proposed method has improved the prediction performance over the existing work, thus proving the importance of addressing problems pertaining to class imbalance in the data. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12859-016-1377-y) contains supplementary material, which is available to authorized users. BioMed Central 2016-12-22 /pmc/articles/PMC5259867/ /pubmed/28155697 http://dx.doi.org/10.1186/s12859-016-1377-y Text en © The Author(s) 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Ezzat, Ali
Wu, Min
Li, Xiao-Li
Kwoh, Chee-Keong
Drug-target interaction prediction via class imbalance-aware ensemble learning
title Drug-target interaction prediction via class imbalance-aware ensemble learning
title_full Drug-target interaction prediction via class imbalance-aware ensemble learning
title_fullStr Drug-target interaction prediction via class imbalance-aware ensemble learning
title_full_unstemmed Drug-target interaction prediction via class imbalance-aware ensemble learning
title_short Drug-target interaction prediction via class imbalance-aware ensemble learning
title_sort drug-target interaction prediction via class imbalance-aware ensemble learning
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5259867/
https://www.ncbi.nlm.nih.gov/pubmed/28155697
http://dx.doi.org/10.1186/s12859-016-1377-y
work_keys_str_mv AT ezzatali drugtargetinteractionpredictionviaclassimbalanceawareensemblelearning
AT wumin drugtargetinteractionpredictionviaclassimbalanceawareensemblelearning
AT lixiaoli drugtargetinteractionpredictionviaclassimbalanceawareensemblelearning
AT kwohcheekeong drugtargetinteractionpredictionviaclassimbalanceawareensemblelearning